C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients.

PubWeight™: 1.50‹?› | Rank: Top 4%

🔗 View Article (PMID 12147774)

Published in Nephrol Dial Transplant on January 01, 2002

Authors

Christoph Wanner1, Thomas Metzger

Author Affiliations

1: Department of Medicine, Division of Nephrology, University Clinic of Würzburg, Germany.

Articles citing this

Transplant nephrectomy improves survival following a failed renal allograft. J Am Soc Nephrol (2009) 2.56

Management of cardiovascular disease in patients with kidney disease. Nat Rev Cardiol (2013) 1.23

Hypoalbuminaemia--a marker of cardiovascular disease in patients with chronic kidney disease stages II-IV. Int J Med Sci (2008) 0.91

Effect of resistance training during hemodialysis on circulating cytokines: a randomized controlled trial. Eur J Appl Physiol (2010) 0.88

Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective. Ther Adv Chronic Dis (2012) 0.84

Inflammatory marker but not adipokine predicts mortality among long-term hemodialysis patients. Mediators Inflamm (2007) 0.84

Environmental carbon monoxide level is associated with the level of high-sensitivity C-reactive protein in peritoneal dialysis patients. Medicine (Baltimore) (2014) 0.83

The initial vascular access type contributes to inflammation in incident hemodialysis patients. Int J Nephrol (2011) 0.82

Serum Concentrations of F2-Isoprostanes and 4-Hydroxynonenal in Hemodialysis Patients in Relation to Inflammation and Renal Anemia. Biomark Insights (2008) 0.82

High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients. PLoS One (2014) 0.82

The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS study. Clin J Am Soc Nephrol (2011) 0.81

Effect of Vitamin C Supplementation on C-reactive Protein Levels in Patients Undergoing Hemodialysis: A Randomized, Double Blind, Placebo-Controlled Study. Nephrourol Mon (2013) 0.79

Association of a high normalized protein catabolic rate and low serum albumin level with carpal tunnel syndrome in hemodialysis patients. Medicine (Baltimore) (2016) 0.78

Circulating Inflammatory and Hemostatic Biomarkers are Associated with All-Cause Death and Cancer Death in a Population of Community-Dwelling Japanese: the Tanushimaru Study. Clin Med Insights Cardiol (2015) 0.77

Association of Processed Meat Intake with Hypertension Risk in Hemodialysis Patients: A Cross-Sectional Study. PLoS One (2015) 0.76

Association Between Hemodiafiltration and Hypoalbuminemia in Middle-Age Hemodialysis Patients. Medicine (Baltimore) (2016) 0.75

Malnutrition, chronic inflammation and atherosclerosis in dialysis patients. Nephrol Dial Transplant (2003) 0.75

Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc (2016) 0.75

Novel quercetin-3-O-glucoside eicosapentaenoic acid ester ameliorates inflammation and hyperlipidemia. Inflammopharmacology (2015) 0.75

Inflammation and anaemia as predictors of cardiovascular mortality in hemodialysis patients. Hippokratia (2007) 0.75

The association between serum C-reactive protein and macronutrients and antioxidants intake in hemodialysis patients. J Med Life (2015) 0.75

Articles by these authors

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet (2003) 3.70

Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int (2002) 1.33

Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl (2002) 1.16

Advanced glycation end products and mortality in hemodialysis patients. Kidney Int (2002) 1.12

Mouse amnionless, which is required for primitive streak assembly, mediates cell-surface localization and endocytic function of cubilin on visceral endoderm and kidney proximal tubules. Development (2004) 1.10

Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. Kidney Int Suppl (2003) 1.01

Carrier-envelope-phase-stable, 1.2 mJ, 1.5 cycle laser pulses at 2.1 μm. Opt Lett (2012) 0.87

Characterization of early steps in muscle morphogenesis in a Drosophila primary culture system. Fly (Austin) (2011) 0.83

1  kW, 200  mJ picosecond thin-disk laser system. Opt Lett (2017) 0.81

Generation of carrier-envelope-phase-stable 2-cycle 740-microJ pulses at 2.1-microm carrier wavelength. Opt Express (2009) 0.78

Molecular modeling of opioid receptor-ligand complexes. Prog Med Chem (2002) 0.76

Direct regenerative amplification of femtosecond pulses to the multimillijoule level. Opt Lett (2016) 0.75

Thin disk amplifier-based 40 mJ, 1 kHz, picosecond laser at 515 nm. Opt Express (2016) 0.75

Pump-seed synchronization for MHz repetition rate, high-power optical parametric chirped pulse amplification. Opt Express (2012) 0.75

CEP-stable, sub-6 fs, 300-kHz OPCPA system with more than 15 W of average power. Opt Express (2015) 0.75

Active stabilization for optically synchronized optical parametric chirped pulse amplification. Opt Express (2012) 0.75

Active pump-seed-pulse synchronization for OPCPA with sub-2-fs residual timing jitter. Opt Express (2014) 0.75